Edible Garden (EDBL) Q4 2025 earnings review
Top-Line Recovery Masked by a Severe Margin Collapse
Edible Garden returned to revenue growth in Q4 (+6.6% YoY) following earlier strategic exits from low-margin categories. However, the cost of this revenue was catastrophic to the bottom line. Gross margin collapsed to -29% as cost of goods sold vastly exceeded sales, driven by expensive onboarding initiatives with retailers like Kroger and peak-season logistics costs. While management spins this as a 'deliberate investment' to secure 2026 shelf space and pivots the narrative toward a new Ready-To-Drink (RTD) business, the reality is a widening net loss and a precariously low cash balance of $1.1M.
🐂 Bull Case
The company successfully onboarded major accounts like Kroger, adding over 700 retail locations in Q4. This drove a 22.9% YoY increase in cut herbs unit sales and sets up a larger footprint for 2026.
The strategic exit from low-margin floral/lettuce is complete. The future focus is on higher-margin, shelf-stable items and RTD beverages (Kick. Sports Nutrition, Vitamin Whey), aiming for 20-30% future product margins.
🐻 Bear Case
Generating $4.1M in revenue cost the company $5.3M in COGS. Management cannot consistently 'buy' shelf space through negative gross margins without risking insolvency.
With only $1.1M in cash remaining and a Q4 net loss of $5.9M, the company is burning cash at an unsustainable rate just as it announces capital-intensive plans to build a Midwest RTD manufacturing hub.
⚖️ Verdict: 🔴
Bearish. Management's vision of becoming a high-margin CPG/RTD powerhouse is compelling on paper, but the current financial reality is alarming. The massive negative gross margin in Q4 and near-empty cash reserves overshadow the top-line distribution wins.
Key Themes
Catastrophic Q4 Gross Margin Collapse
Gross margin reversed drastically, falling from 9.7% in Q3 to -29.0% in Q4. Management attributed this to 'deliberate investment' in securing 2026 shelf space, accelerated procurement at higher per-unit costs, and above-normal logistics expenses to meet demand. While fulfilling orders to secure relationships is important, operating at a steep negative gross profit is an unsustainable strategy that directly contradicts the narrative of pivoting to a 'higher-margin' business.
Liquidity Under Severe Pressure
Edible Garden ended FY25 with just $1.1M in cash, down from $3.5M at the end of FY24. Given the Q4 net loss of $5.9M and operating loss of $5.7M, the current cash burn rate is a massive red flag. The company's ambitious plans to build out a state-of-the-art Tetra Pak RTD facility in the Midwest will require significant CapEx, which appears entirely unfunded at this moment.
Ready-To-Drink (RTD) Expansion with Tetra Pak
The company is aggressively moving into the RTD space, selecting Tetra Pak to integrate processing capabilities at its Midwest facility (Prairie Hills). Management views this as the ultimate growth driver, targeting the $842B global RTD market. The plan is to produce sports nutrition and protein beverages (under brands like Kick. and private labels) with projected future margins of 20-30%. If executed, this would fundamentally transform the business model.
Retail Footprint Acceleration
Accelerating distribution growth was the bright spot of Q4. The company added over 700 retail locations, pushing its total network to nearly 6,000 doors. Key wins included a major USDA Organic fresh potted and cut herbs program with Kroger, alongside expansion in Weis Markets, The Fresh Market, and Safeway. This drove a 22.9% YoY increase in cut herbs unit sales.
International and E-Commerce Traction
The Vitamin and Supplement product lines are finding success beyond domestic brick-and-mortar. International unit sales for nutraceuticals grew approximately 100% YoY, highlighted by the first shipments of Kick. Sports Nutrition to PriceSmart in Latin America and the Caribbean. E-commerce placements on Amazon, Target.com, and Walmart.com are also expanding.
SG&A Expense Bloat
Selling, General, and Administrative expenses surged to $4.6M in Q4, up 64% from $2.7M a year ago. Management cited depreciation and rent tied to the NaturalShrimp asset acquisition, legal/professional fees, and higher compensation. While framed partially as 'nonrecurring or deal-related,' this overhead bloat further cripples the path to profitability.
Other KPIs
While total FY25 revenue fell to $12.8M from $13.9M, this was driven entirely by the strategic exit of low-margin floral and lettuce categories (which management noted previously accounted for ~$1M in lost revenue). Excluding those exits, core revenue was flat for the year, and Q4 saw a return to positive growth (+6.6% YoY) led by the legacy herb business.
Accelerating demand for the CPG side of the portfolio. This segment includes Kick. Sports Nutrition, Jealousy GLP-1, and Vitamin Whey. However, management noted on the call that much of this product is co-manufactured, which caps the margin upside compared to vertically integrated production.
Guidance
Accelerating from flat YoY growth in FY25 (excluding exited categories). Management expects steady growth driven by the recent customer wins (Kroger, Safeway) and a normalized production environment.
Accelerating. The company expects strong double-digit growth (around 20%) for its vitamin and supplement portfolio, buoyed by international expansion (PriceSmart) and deeper domestic retail penetration.
Reversing. Following the -29% disaster in 25Q4, management is guiding for 'low double digits to mid-teens' blended margins going forward. This assumes the elevated third-party procurement and logistics costs normalize as Q4 onboarding programs mature.
Management expects the new Ready-To-Drink platform, once operational, to yield significantly richer margins than the co-manufactured nutraceuticals or core fresh produce lines.
Key Questions
Funding the RTD Buildout
With only $1.1M in cash on the balance sheet and a $5.9M net loss this quarter, how exactly does the company plan to finance the capital expenditures required to retrofit the Midwest facility and install Tetra Pak equipment for the RTD launch?
Timeline for Margin Normalization
You described Q4's -29% gross margin as a deliberate investment in onboarding elevated costs. In exactly which quarter of 2026 do you expect gross margins to flip back to positive, and what specific operational shifts trigger that recovery?
Co-Manufacturing vs Vertical Integration
You noted that current nutraceuticals are largely co-manufactured, capping margins. Will the new Midwest facility take over production of the existing Kick. and Vitamin Whey powders, or is it strictly dedicated to the new liquid RTD lines?